• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 25 Mar

    Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

    ASHBURN, Va., March 25, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late-stage clinical, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases, today announced it has filed a U.S. patent application for novel topical… Read More..

    Share this:
  • 24 Mar

    SKYX Reports 48% Revenue Growth in 2024 — From $58.8 Million in 2023 to $86.3 Million in 2024

    MIAMI, March 24, 2025 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced and smart home platform technology company with over 97 U.S. and Global pending and issued patents and a portfolio of over 60 lighting and home… Read More..

    Share this:
  • 24 Mar

    NextNRG Delivers Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments

    NEW YORK, NY, March 24, 2025 (EZ Newswire) -- PRISM MarketView has released an exclusive interviewwith Michael Farkas, CEO of NextNRG, Inc. (NASDAQ: NXXT), highlighting the company’s record-breaking growth and its role at the forefront of the AI-powered energy revolution. As global demand for decentralized, sustainable, and intelligent energy solutions… Read More..

    Share this:
« Previous 1 … 31 32 33 34 35 … 254 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact